The treatment of cancer is increasingly guided by its clinical phenotypes. For example, the presence of hormone receptors in breast cancer cells can determine the use of hormone therapy. Similarly, the identification of microsatellite instability in colorectal cancer can predict responsiveness to immunotherapy. By tailoring treatment to the specific characteristics of the cancer, clinicians can improve outcomes and minimize side effects.
